Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective.

Objective. Malignancy in giant cell tumor of bone (mGCTB) is categorized as primary (concomitantly with conventional GCTB) or secondary (after radiotherapy or other treatment). Denosumab therapy has been suggested to play a role in the etiology of secondary mGCTB. In this case series from a tertiary...

Descripción completa

Detalles Bibliográficos

Publicado en:	Sarcoma pp. 1 - 12
Autores principales:	van Langevelde, K., Cleven, A. H. G., Navas Cañete, A., van der Heijden, L., van de Sande, M. A. J., Gelderblom, H., Bovée, J. V. M. G.
Formato:	diagnostic images pictorial research tables/charts Journal Article
Publicado:	Wiley-Blackwell 7/5/2022
Acceso en línea:	Ver este registro en EBSCOhost